Ligand Pharmaceuticals Incorporated (LGND)
Jul 2, 2025 - LGND was delisted (reason: merged into PTHS)
113.30
+0.74 (0.66%)
Inactive · Last trade price on Jul 2, 2025
Ligand Pharmaceuticals Employees
Ligand Pharmaceuticals had 68 employees as of December 31, 2024. The number of employees increased by 10 or 17.24% compared to the previous year.
Employees
68
Change (1Y)
10
Growth (1Y)
17.24%
Revenue / Employee
$2,668,941
Profits / Employee
-$1,950,324
Market Cap
2.75B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 68 | 10 | 17.24% |
Dec 31, 2023 | 58 | -18 | -23.68% |
Dec 31, 2022 | 76 | -78 | -50.65% |
Dec 31, 2021 | 154 | -1 | -0.65% |
Dec 31, 2020 | 155 | 40 | 34.78% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
LGND News
- 4 days ago - Ligand to Participate in September Investor Conferences - GlobeNewsWire
- 9 days ago - Ligand Announces Closing of Convertible Senior Notes Offering - GlobeNewsWire
- 11 days ago - Ligand Announces Pricing of $400 Million Convertible Senior Notes Offering - GlobeNewsWire
- 12 days ago - Ligand Announces Proposed Offering of $400 Million of Convertible Senior Notes Due 2030 - GlobeNewsWire
- 15 days ago - Ligand Pharmaceuticals Incorporated (LGND) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 16 days ago - Ligand Reports Second Quarter 2025 Financial Results and Raises Guidance - GlobeNewsWire
- 23 days ago - Ligand and Medtronic Commit $70 Million in Strategic Capital to Orchestra BioMed - GlobeNewsWire
- 4 weeks ago - Ligand to Report Second Quarter 2025 Financial Results on August 7, 2025 - GlobeNewsWire